Browsing by Author "Sadalaki, J."
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Effects of a lipid-based nutrient supplement during pregnancy and lactation on maternal plasma fatty acid status and lipid profile: Results of two randomized controlled trials(Prostaglandins Leukotrienes and Essential Fatty Acids, 2017-02) Oaks, B.M.; Young, R.R.; Adu-Afarwuah, S.; Ashorn, U.; Jackson, K.H.; Lartey, A.; Maleta, K.; Okronipa, H.; Sadalaki, J.; Baldiviez, L.M.; Shahab-Ferdows, S.; Ashorn, P.; Dewey, K.G.It is unknown whether a novel small-quantity lipid-based nutrient supplement (SQ-LNS) containing alpha-linolenic (ALA) and linoleic acids impacts maternal plasma lipids and fatty acid status. We measured plasma fatty acids (wt%) and lipid concentrations at 36 wk gestation and breast milk fatty acids (wt%) at 6 months postpartum in a subsample of women enrolled in a randomized controlled trial studying the effects of SQ-LNS on birth outcomes and child growth. Women≤20 wk gestation in Ghana (n=1,320) and Malawi (n=1,391) were assigned to receive daily either: 1) iron-folic acid (pregnancy); 2) multiple micronutrients (pregnancy and lactation); or 3) SQ-LNS (pregnancy and lactation). At 36 wk, plasma ALA levels were higher in those receiving SQ-LNS. SQ-LNS increased breast milk ALA in Ghana but not Malawi. There was no effect on plasma lipids or other selected fatty acids. SQ-LNS may impact plasma and breast milk ALA levels depending on the population. © 2017 The AuthorsItem Prenatal Iron Deficiency and Replete Iron Status Are Associated with Adverse Birth Outcomes, but Associations Differ in Ghana and Malawi(Journal of Nutrition, 2019-03) Oaks, B.M.; Jorgensen, J.M.; Baldiviez, L.M.; Adu-Afarwuah, S.; Maleta, K.; Okronipa, H.; Sadalaki, J.; Lartey, A.; Ashorn, P.; Ashorn, U.; Vosti, S.; Allen, L.H.; Dewey, K.G.Background:Previous literature suggests a U-shaped relation between hemoglobin concentration and adverse birthoutcomes. There is less evidence on associations between iron status and birth outcomes.Objective:Our objective was to determine the associations of maternal hemoglobin concentration and iron status withbirth outcomes.MethodsWe conducted a secondary data analysis of data from 2 cohorts of pregnant women receiving iron-containingnutritional supplements (20–60 mg ferrous sulfate) in Ghana (n=1137) and Malawi (n=1243). Hemoglobin concentrationand 2 markers of iron status [zinc protoporphyrin and soluble transferrin receptor (sTfR)] were measured at≤20 weeksand 36 weeks of gestation. We used linear and Poisson regression models and birth outcomes included preterm birth(PTB), newborn stunting, low birth weight (LBW), and small-for-gestational-age.Results:Prevalence of iron deficiency (sTfR>6.0 mg/L) at enrollment was 9% in Ghana and 20% in Malawi. In earlypregnancy, iron deficiency was associated with PTB (9% compared with 17%, adjusted RR: 1.63; 95% CI: 1.14, 2.33)and stunting (15% compared with 23%, adjusted RR: 1.44; 95% CI: 1.09, 1.94) in Malawi but not Ghana, and was notassociated with LBW in either country; replete iron status (sTfR<10th percentile) was associated with stunting (9%compared with 15%, adjusted RR: 1.71; 95% CI: 1.06, 2.77) in Ghana, but not PTB or LBW, and was not associated withany birth outcomes in Malawi. In late pregnancy, iron deficiency was not related to birth outcomes in either country andiron-replete status was associated with higher risk of LBW (8% compared with 16%, adjusted RR: 1.90; 95% CI: 1.17,3.09) and stunting (6% compared with 13%, adjusted RR: 2.14; 95% CI: 1.21, 3.77) in Ghana, but was not associatedwith birth outcomes in Malawi.Conclusions:The associations of low or replete iron status with birth outcomes are population specific. Research toreplicate and extend these findings would be beneficial. These trials were registered atclinicaltrials.govas NCT00970866(Ghana) and NCT01239693 (Malawi).J Nutr2019;149:513–521.